IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Virpax Pharmaceuticals Inc

CUSIP: 928251107 | 39 institutional holders

Quarters

Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023
CompareDetailedHistoricalFundsOptions13D/13GPeersTargetingTrading SummaryProfile

Institutional Holders — Q2 2024

Parallel Advisors, LLC1
0.0% of portfolio›$1
StyleTurnoverLocationFiled
Parallel Advisors, LLC
1$10.0%IndexLowSan Francisco, CA2024-08-08